AIDS TREATMENT NEWS #343, May 19, 2000
John S. James
* On May 11, five major pharmaceutical companies and UNAIDS (the Joint United Nations Programme on HIV/AIDS) announced an agreement to negotiate large price reductions for poor countries, for AIDS drugs only; the reductions could be as much as 85% to 90% from what is paid in the U.S., according to an article in the WALL STREET JOURNAL, May 11, 2000.
* On May 16, the U.S. House of Representatives unanimously passed the World Bank AIDS Marshall Plan Trust Fund Act, which would provide $100 million per year for five years, to be leveraged with other government and private contributions for AIDS prevention and care. This bill could become law, possibly this year.
* On May 10, President Clinton signed an executive order which "prohibits the United States Government from [bringing trade sanctions] with respect to any law or policy in beneficiary sub-Saharan African countries that promotes access to HIV/AIDS pharmaceuticals or medical technologies and the provides adequate and effective intellectual property protection consistent with the TRIPS agreement" [of the World Trade Organization treaty]. The language of this executive order was taken almost verbatim from an amendment by Senator Diane Feinstein (D-CA) to an African trade bill, after Republicans took that provision out of the bill, over Senator Feinstein's strong objection.
* Shortly after this issue goes to press, representatives of 30 different churches in the Chicago area will be meeting "to forge an historic partnership between communities of faith, HIV/AIDS-treatment physicians, and a pharmaceutical industry leader to combat the AIDS crisis by providing a model program for the care and support of HIV-infected children in Africa." This gathering is organized by the International Association of Physicians in AIDS Care (IAPAC), with support from Bristol-Myers Squibb Company's Secure the Future initiative.
Incidentally, some practical issues of dealing with AIDS in many developing countries (focusing on Zimbabwe) are outlined in a May 2000 SCIENTIFIC AMERICAN article, "Care for a Dying Continent."
Comment
We have not had time to analyze the various proposals. At this time almost everything is talk, and most of the details are missing. But almost all complex programs start that way.
We believe that the AIDS community should avoid quick judgments on these proposals, either positive or negative. Events are moving very rapidly, and new people and institutions are getting involved. It is more important to have top people focusing on the right issues than to have programs we can control.
000519
ATN34301
Copyright © 2000 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .